Table 6.
Costs of Integrative Oncology Care in Women With Breast Cancer (US$).a
| Stage at FOC | Treatment Period | Patients, Percentage (n) | Mean Cost/Patient for Office Visits | IO Recommendations |
Total Average Cost/Patient | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diet, Percentage of Patients (n), Mean Cost/Patient | IV, Percentage of Patients (n), Mean Cost/Patient | Lifestyle, Percentage of Patients (n), Mean Cost/Patient | Mind-Body, Percentage of Patients (n), Mean Cost/Patient | Supplements, Percentage of Patients (n), Mean Cost/Patient | TCM, Percentage of Patients (n), Mean Cost/Patient | |||||
| Stage 0 | In treatment | 8.69 (16) | 712.90 | 43.75 (7), 32.50 | 18.75 (3), 3600.01 | 31.25 (5), 156.00 | 25.00 (4), 0.00 | 100.00 (16), 1554.15 | 43.75 (7), 410.17 | 3184.47 |
| Survivorship | 5.68 (10) | 536.59 | 30.00 (3), 75.83 | 20.00 (2), 2264.24 | 50.00 (5), 0.00 | 20.00 (2), 390.00 | 100.00 (10), 776.02 | 20.00 (2), 257.21 | 1917.65 | |
| Total | 6.62 (19) | 804.96 | 42.10 (8), 56.87 | 21.05 (4), 3832.13 | 52.63 (10), 78.00 | 31.57 (6), 130.00 | 100.00 (19), 1527.73 | 42.10 (8), 364.28 | 3398.89 | |
| Stage 1 | In treatment | 33.69 (62) | 583.08 | 64.51 (40), 102.37 | 8.06 (5), 1907.38 | 61.29 (38), 184.73 | 32.25 (20), 487.50 | 100.00 (62), 1503.68 | 30.64 (19), 471.35 | 2721.58 |
| Survivorship | 14.20 (25) | 617.44 | 40.00 (10), 136.50 | 8.00 (2), 2312.12 | 40.00 (10), 156.00 | 28.00 (7), 334.28 | 84.00 (21), 1057.66 | 28.00 (7), 471.36 | 2033.43 | |
| Total | 23.34 (67) | 694.19 | 65.67 (44), 108.57 | 8.95 (6), 1590.23 | 62.68 (42), 204.28 | 40.29 (27), 447.77 | 100.00 (67), 1612.40 | 35.82 (24), 471.36 | 2997.66 | |
| Stage 2 | In treatment | 38.58 (71) | 744.27 | 74.64 (53), 98.72 | 16.90 (12), 1978.87 | 70.42 (50), 124.79 | 33.80 (24), 682.50 | 100.00 (71), 1810.97 | 57.74 (41), 463.01 | 3549.36 |
| Survivorship | 18.75 (33) | 728.55 | 39.39 (13), 52.50 | 6.06 (2), 2264.24 | 36.36 (12), 0.00 | 33.33 (11), 1099.09 | 96.96 (32), 1128.16 | 24.24 (8), 471.36 | 2461.07 | |
| Total | 26.13 (75) | 944.59 | 80.00 (60), 91.00 | 18.66 (14), 2019.64 | 72.00 (54), 115.55 | 40.00 (30), 858.00 | 100.00 (75), 1966.60 | 60.00 (45), 463.75 | 4065.64 | |
| Stage 3 | In treatment | 10.86 (20) | 878.05 | 60.00 (12), 37.91 | 35.00 (7), 2684.91 | 70.00 (14), 167.14 | 45.00 (9), 780.00 | 100.00 (20), 2109.61 | 70.00 (14), 446.92 | 4730.98 |
| Survivorship | 10.22 (18) | 521.6 | 50.00 (9), 126.38 | 16.66 (3), 4589.32 | 22.22 (4), 0.00 | 16.66 (3), 1950.00 | 88.88 (16), 1348.33 | 33.33 (6), 471.36 | 3030.32 | |
| Total | 9.40 (27) | 915.17 | 74.07 (20), 79.62 | 37.03 (10), 3256.24 | 62.96 (17), 137.64 | 44.44 (12), 1072.50 | 100.00 (27), 2163.51 | 74.07 (20), 454.25 | 5243.50 | |
| Stage 4 | In treatment | 5.43 (10) | 731.87 | 30.00 (3), 75.83 | 20.00 (2), 2314.37 | 50.00 (5), 0.00 | 30.00 (3), 520.00 | 100.00 (10), 1647.57 | 80.00 (8), 476.74 | 3402.47 |
| Survivorship | 3.97 (7) | 590.91 | 14.28 (1), 0.00 | 28.57 (2), 6881.74 | 42.85 (3), 0.00 | 42.85 (3), 0.00 | 71.42 (5), 789.89 | 14.28 (1), 471.36 | 3188.67 | |
| Total | 4.18 (12) | 900.89 | 25.00 (3), 75.83 | 33.33 (4), 4598.05 | 58.33 (7), 0.00 | 41.66 (5), 312.00 | 100.00 (12), 1694.11 | 66.66 (8), 476.74 | 4594.48 | |
| Unknown | In treatment | 2.71 (5) | 992.25 | 40.00 (2), 227.50 | 40.00 (2), 6033.49 | 20.00 (1), 0.00 | 40.00 (2), 975.00 | 100.00 (5), 2030.14 | 60.00 (3), 485.71 | 6208.23 |
| Survivorship | 47.15 (83) | 1254.88 | 50.60 (42), 70.41 | 43.37 (36), 6830.81 | 39.75 (33), 141.81 | 34.93 (29), 712.75 | 98.79 (82), 1483.60 | 39.75 (33), 462.29 | 6208.24 | |
| Total | 30.31 (87) | 1137.13 | 50.57 (44), 77.55 | 43.67 (38), 6788.85 | 39.08 (34), 137.64 | 35.63 (31), 729.67 | 98.85 (86), 1532.63 | 41.37 (36), 464.24 | 6162.51 | |
| Total n (all stages) | In treatment | 184 | ||||||||
| Survivorship | 176 | |||||||||
| Total | 287 | |||||||||
Abbreviations: IO, integrative oncology; TCM, traditional Chinese medicine; FOC, first office call.
Cost of IO care for IO patients with 2 or more IO physician consultations. Includes cohort 1 patients from all sites with a signed MRR and known diagnosis date enrolled in the study before January 1, 2014, and who had had at least 2 consultations with an IO physician. Included are the first 12 months of IO recommendations. Consultations are office visits with procedure codes indicating interaction with an IO physician. “In treatment” refers to any patient <1 year postdiagnosis who has a completed IO treatment eCRF dated before the 1-year diagnosis anniversary. “Survivorship” refers to any patient >1 year postdiagnosis who has a completed IO treatment eCRF dated after the 1-year diagnosis anniversary. Office visit mean cost/patient is for consultations only, based on average cost of $238.52 for a first office visit and $137.04 for a follow-up visit. Office visit costs were calculated from Bastyr Integrative Oncology Clinic patient data.